These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24486136)

  • 21. Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomes.
    Westley IS; Morris RG; Evans AM; Sallustio BC
    Drug Metab Dispos; 2008 Jan; 36(1):46-50. PubMed ID: 17908922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
    Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
    Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG; Harmon M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
    Brown NW; Aw MM; Mieli-Vergani G; Dhawan A; Tredger JM
    Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.
    Naesens M; Kuypers DR; Verbeke K; Vanrenterghem Y
    Transplantation; 2006 Oct; 82(8):1074-84. PubMed ID: 17060857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
    Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
    J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation.
    Zucker K; Tsaroucha A; Olson L; Esquenazi V; Tzakis A; Miller J
    Ther Drug Monit; 1999 Feb; 21(1):35-43. PubMed ID: 10051052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
    Miura M; Kagaya H; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase.
    Mino Y; Naito T; Otsuka A; Takayama T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharm Ther; 2011 Apr; 36(2):217-24. PubMed ID: 21366651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
    Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
    Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.
    Cremers S; Schoemaker R; Scholten E; den Hartigh J; König-Quartel J; van Kan E; Paul L; de Fijter J
    Br J Clin Pharmacol; 2005 Sep; 60(3):249-56. PubMed ID: 16120063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
    Geng F; Jiao Z; Dao YJ; Qiu XY; Ding JJ; Shi XJ; Li ZD; Zhong MK
    Clin Chim Acta; 2012 Apr; 413(7-8):683-90. PubMed ID: 22227166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.
    Saitoh H; Kobayashi M; Oda M; Nakasato K; Kobayashi M; Tadano K
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):406-13. PubMed ID: 17072094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats.
    Mähler N; Freyer M; Kauschke R; Schlüter T; Steinbach AC; Oswald S; Miehe B; Krebs A; Rettig R; Grisk O
    Pharmacogenet Genomics; 2012 Jun; 22(6):408-20. PubMed ID: 21869731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
    Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study.
    Lloberas N; Torras J; Cruzado JM; Andreu F; Oppenheimer F; Sánchez-Plumed J; Gentil MÁ; Brunet M; Ekberg H; Grinyó JM;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3784-93. PubMed ID: 21427078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.
    Mandla R; Midtvedt K; Line PD; Hartmann A; Bergan S
    Transpl Int; 2006 Jan; 19(1):44-53. PubMed ID: 16359376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.